Bionime Corporation
4737
Rank in Stocks
#18528
Bionime Corporation, headquartered in Taichung, Taiwan, specializes in the... Bionime Corporation, headquartered in Taichung, Taiwan, specializes in the development, production, and global distribution of medical instruments. The company maintains a significant international presence, serving markets in countries such as China, Switzerland, the United States, Algeria, and Egypt. Its primary product line features blood glucose monitoring systems, along with essential complementary items like test strips and lancing devices. These healthcare solutions are supplied to a varied customer base, including hospitals, pharmacies, and other medical equipment enterprises. Beyond its core medical device business, Bionime also engages in providing biotechnology-related services, performing pharmaceutical analysis, and marketing high-precision tools. The company was founded in 2003.
Share Price
$1.69
Last synced: 2026-11-10
Market Cap
$130.76M
Change (1 day)
-3.14%
Change (1 year)
-16.80%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bionime Corporation (4737)
Category
Healthcare
EPS for Bionime Corporation (4737)
EPS as of June 2026 TTM: $-0.12
According to Bionime Corporation's latest financial reports, its current EPS (TTM) is $-0.12. At the end of 2025 the company had an EPS of $-0.08, a decrease compared to its 2024 EPS of $-0.06.
EPS history for Bionime Corporation from 2009 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.12 | 55.50% |
| 2025 | $-0.08 | 45.02% |
| 2024 | $-0.06 | -2,040.00% |
| 2023 | 0.00 | -93.26% |
| 2022 | $0.04 | -7.10% |
| 2021 | $0.05 | 39.65% |
| 2020 | $0.03 | -38.97% |
| 2019 | $0.06 | -15.23% |
| 2018 | $0.07 | -14.12% |
| 2017 | $0.08 | -2.28% |
| 2016 | $0.08 | 49.62% |
| 2015 | $0.05 | 50.86% |
| 2014 | $0.04 | -43.91% |
| 2013 | $0.06 | 165.53% |
| 2012 | $0.02 | -80.48% |
| 2011 | $0.12 | 4.60% |
| 2010 | $0.12 | 17.33% |
| 2009 | $0.10 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.37 | -6,828.30% |
US
|
|
| $6.02 | -4,940.76% |
FR
|
|
| $4.15 | -3,436.01% |
US
|
|
| $5.32 | -4,376.61% |
JP
|
|
| $0.67 | -638.59% |
US
|
Questions about Bionime Corporation's earnings per share (EPS)
What is Bionime Corporation's earnings per share (EPS)?
Bionime Corporation's earnings per share (EPS) over the last twelve months is $-0.12, as of Jun 2026.
What was Bionime Corporation's earnings per share (EPS) in 2025?
In 2025, Bionime Corporation's earnings per share (EPS) was $-0.08, compared with $-0.06 in 2024.
How has Bionime Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Bionime Corporation's earnings per share (EPS) was highest in 2021 ($0.05) and lowest in 2025 ($-0.08).
How does Bionime Corporation's earnings per share (EPS) compare with similar companies?
Bionime Corporation's earnings per share (EPS) ($-0.12) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.